Ignite Creation Date:
2024-05-05 @ 4:46 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00319111
Status:
COMPLETED
Last Update Posted:
2012-12-31
First Post:
2006-04-26
Brief Title:
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension CTEPH
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Long-term Open-label Extension Study in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension CTEPH Who Completed Protocol AC-052-366 BENEFIT NCT00313222
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BENEFIT OL
Brief Summary:
The present trial investigates the long-term safety tolerability and efficacy of bosentan in patients with inoperable CTEPH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| BENEFIT OL | None | None | None |